Consort Med Plc ADR (CSRMY) 13.9500 $CSRMY Drug
Post# of 273240
Posted On: 09/25/2016 3:09:58 AM
Consort Med Plc ADR (CSRMY) 13.9500 $CSRMY
Drug Delivery Market Analysis - Forecast (2015-2020) - Prominent Players are 3M, Abbott Laboratories, Thermo Fischer Scientific, Medtronics, Roche & Baxter
M2 - Wed Jan 20, 5:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/wktqdq/drug_delivery) has announced the addition of the "Drug Delivery Market Analysis - Forecast (2015-2020)." report to their offering. The practice of drug delivery has changed dramatically in the last few decades. With Drug Delivery devices, medication discovered using the most advanced molecular biology strategies and having unacceptable side effects dues to drug interaction with parts of the body that are not target of drugs can be avoided. Drug delivery systems control the rate at which a drug is released and the target in the body where it is released. Side effects limits our ability to treat many diseases like neurodegenerative diseases, cancer, and infectious diseases; it is possible now with drug delivery devices. Administration of drug locally rather than systemically is a way to reduce side effect and drug toxicity and obtain maximum treatment impact. Application of ointment locally and injection of steroid to avoid joint pain are the few older ways to systemic delivery, there can be other ways to deliver drug systemically but some medications can be given only systemically. Here the role of drug delivery device comes into play. In this report different market aspects are explored with particular focus on key market drivers, challenges, constraints and market landscape. The Global market has been thoroughly analyzed and carefully segmented by geographic locations based on major economic and topographical regions. The market is classified into several categories based on technology, applications and end users. Insulin Pen & Pump is the biggest revenue generating segment by type of technology used. Major market players are profiled along with company overview, financial status, business strategies, product portfolio, recent trends and developments. Companies Mentioned: - 3M - Abbott Laboratories - Abbvie - Baxter - B Braun - Consort Medical - Eli-Lilly - Hospira - Hill-Rom - Insulet - Mylan - Medtronic - Omron - Paragard - Roche - Smiths Medical - Thermo Fischer Scientific - Unilife - Zyno medical Key Topics Covered: 1. Market Overview 2. Executive Summary 3. Market Landscape 4. Market Forces 5. Government Regulations 6. Strategic Analysis 7. By Type 8. By Application 9. By End Users 10. Geographic Analysis 11. Market Entropy 12. Company Profiles For more information visit http://www.researchandmarkets.com/research/wk...g_delivery
ABT: 42.19 (-0.03), MDT: 87.71 (-0.11)
Global COPD and Asthma Devices Market Industry Analysis 2015-2019
M2 - Thu Nov 12, 9:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/vb94x6/global_copd_and) has announced the addition of the "Global COPD and Asthma Devices Market - Industry Analysis 2015-2019" report to their offering. The global COPD and asthma devices market to grow at a CAGR of 3.76% over the period 2014-2019. The report, Global COPD and Asthma Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends. Vendors are expanding online marketing and promotional activities to provide better accessibility of their products to customers and increase product sales. This strategy also allows vendors to minimize sales mediators, distribution, and reduce operational costs. Many small, medium, and large vendors sell inhalers and nebulizers and their accessories online, proving to be a convenience for consumers. Some of the vendors also provide discounts and promotional offers online, which has increased the overall online purchase. The products offered online also come with a warranty or guarantee from the manufacturer. According to the report, the rising incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis increases the demand for aerosol drug delivery devices. Exposure to allergens, smoking, and infections in the respiratory tract could cause the lungs to fill with mucus, leading to breathing difficulties. Using aerosol-based mechanism allows the drugs to reach the lungs immediately, helping the person breathe. We also expect the growing use of home medical devices to propel market growth. Home healthcare devices are reliable, comfortable, and easy to use. Further, the report states that stringent government regulations regarding the safety, quality, and efficacy of COPD and asthma devices hinder market growth. The devices have to comply with numerous standards to enter the market. Obtaining approval is both a lengthy and costly process. To calculate the market size, the report considers revenue generated from the sales of following COPD and asthma devices: - Inhalers - Nebulizers Key vendors - Consort Medical - Gerresheimer - Nypro - Philips Healthcare - RPC Bramlage Other prominent vendors - Aerogen - Airon - Allied Healthcare - AstraZeneca - Boehringer Ingelheim - Briggs Healthcare - Cardinal Health - Clement Clarke International - DeVilbiss Healthcare - Drive Medical - GlaxoSmithKline - Heyer Medical - Invacare - Omron Healthcare - PARI Medical - Salter Labs - Smart Inhaler - Sunovion Pharmaceuticals - Teleflex - Vortran Medical For more information visit http://www.researchandmarkets.com/research/vb...l_copd_and
IVC: 10.99 (-0.07), GSK: 43.42 (-0.16)
Leading 200 Global Multinational Medical Devices/Technology/Supplies Companies with Major Manufacturing and R&D
M2 - Thu Oct 22, 2:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nngj7n/_global) has announced the addition of the " Global Geographic Frontiers Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 global multinational medical devices/technology/supplies companies with manufacturing and research, and covers various analyses to identify countries that should be considered by such companies for new medical devices manufacturing and research. When it comes to medical device product development, the fragmentation of the industry can be challenging. Medical device development and manufacturing have seen many changes in the last decade. Not too long ago, manufacturing anything in a different country was risky and time intensive but now new communication technologies have allowed for the rapid development and manufacturing of medical devices overseas which has reduced costs and time to market. Developed and developing countries are investing in high quality medical device manufacturing facilities that allow sourcing of design and manufacturing throughout the world. However, recently, the medical device manufacturers have also been looking beyond their traditional markets in the United States and EU, focusing instead on emerging economies such as Brazil, Russia, India, and Chinacollectively known as the BRIC nations for growth. But as companies flock to the BRICs and the medtech markets in these countries mature, forward-thinking device makers are searching for the next group of emerging medtech markets. Among those that show promise are the 10 countries that comprise the Association of Southeast Asian Nations (ASEAN)Indonesia, Malaysia, the Philippines, Singapore, Thailand, Brunei, Myanmar, Cambodia, Laos, and Vietnam. Highlights - Identifies leading global multinational medical devices/technology/supplies companies with major manufacturing and R&D - Identifies top 200 among such companies based on total sales, net income, total assets, and total equity - Identifies home and foreign countries for manufacturing and research facilities of leading global geographic frontiers medical devices/technology/supplies companies - Summary of company news for expansion into new countries for leading global medical devices/ technology/supplies companies - Summary of initiatives taken up by government countries to support setting up of manufacturing facilities - Comprehensive listing of leading global geographic frontiers medical devices/technology/supplies companies covered in the study Key Topics Covered: 1: GMD Sales, R&D Expenses, and Foreign Sales for Top 25 Countries by Population 2: Leading 200 Global Multinational Medical Devices/Technology/Supplies Companies with Major Manufacturing and R&D (based on total sales, net income, total assets, total equity) 3: Home Countries having Manufacturing Units in Foreign Countries 4: Home Countries having Research & Development Units in Foreign Countries 5: Popular Foreign Countries for Manufacturing Units 6: Popular Foreign Countries for Research & Development Units 7: Comparison of Manufacturing and Research & Development Units of Home and Foreign Companies in Home Countries 8: Global Medical Devices/Technology/Supplies Companies which Expanded into New Countries in Last 2 Years 9: Government Initiatives to Support Setting Up of Manufacturing Facilities for Medical Devices/Technology/Supplies Companies Mentioned - Partial List - Biotage AB - Boston Scientific Corporation - Boule Diagnostics AB - Bruker Corporation - CRH Medical Corp. - Cambridge Cognition Holdings Plc - Cardica, Inc. - Carl Zeiss Meditec AG - Cellavision AB - Coloplast AS - Coltene Holding AG - Comet Holding AG - Conmed Corporation - Consort Medical Plc - ContextVision - Cooper Companies, Inc. - Cormedix - Covidien Plc - Cutera, Inc. - Cyberoptics Corporation - Cyclopharm Limited - Cynosure Inc - Danaher Corp. - Dentsply International Incorporated - DiaSorin Inc. - Dipped Products Plc - Draegerwerk AG & Co KGaA - EKF Diagnostics Holdings PLC For more information visit http://www.researchandmarkets.com/research/nngj7n/_global
CYNO: 52.93 (-1.24), CRHM: 3.95 (-0.11), DHR: 77.59 (-0.08), COO: 180.97 (-3.53), BSX: 23.71 (-0.02), CRDC: 2.35 (-0.15)
Contract Research Organization Market - Global Deals and Operational Strategies
M2 - Thu Oct 08, 3:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3xpsnr/contract_research) has announced the addition of the "Contract Research Organization Market - Global Deals and Operational Strategies" report to their offering. This report discusses the deals that took place in the CRO space between 2010 and April 2015, giving a thorough analysis of the major deals, operational and service strategies, and financials of key players. This report discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs. The operational strategies adopted by key players in the recent years have been listed. A heatmap analysis of the key companies was done based on their firm utilization and capital management. SWOT analysis and profiles are given for the key companies in the market. Recent years have seen pharmaceutical companies struggling to balance R&D expenditure and profitability due to the rising costs of drug development and clinical trials, along with rigorous regulatory and quality assurance requirements. In a bid to boost profit margins, companies are outsourcing R&D and clinical trial activities to Contract Research Organizations (CRO) to achieve far more at a far lower cost. Scope - Overview of key reasons behind outsourcing, outsourcing service models - Examples of operational strategies - Global deals analysis by type and value - Major acquisitions and partnerships - Regional analysis of North America, Europe, Asia-Pacific and Emerging markets - Company benchmarking based on heatmap analysis - Vendor positioning - SWOT analysis and profiles of key players Key Reasons to Purchase - Identify the top players in the CRO market, financial revenues and key services offered - Analyze the key geographies that are lucrative markets for deal making, market-entry and market expansion strategies - Analyze the trends in acquisitions, licensing and other type of deals and explore potential investment opportunities - Understand the operational strategies of key players Key Topics Covered: 1. Executive Summary 2. Introduction 2.1 Market Dynamics 2.2 Operating Models 2.3 Examples of Operational Strategies 3. Global Deal Analysis 3.1 Collaborations and Acquisitions 3.2 Major Acquisitions 3.3 Major Partnerships 4. Regional Analysis 4.1 North America 4.2 Europe 4.3 Asia-Pacific 5. Emerging Markets 5.1 Market Assessment 5.2 Acquisitions 5.3 Firm Utilization 5.4 Firm Utilization and Capital Management 5.5 Company Benchmarking 5.6 Vendor Positioning 6. Profiles and SWOT Analysis 7. Appendix Companies Mentioned - Almac Group - Assign - Aurigon - Avillion - BioPharma - CMIC Holdings - Carlina - Catalent - Celonic and PharmaLex - Charles River - Chiltern International - Consort Medical - Covance - Cromos Pharma - EPS Corporation - Euprotech - Eurofins Scientific - Hangzhou Tigermed - Harlan Labs - ICON - Laboratory Corporation of America Holdings - MPI Research - Meiji Seika - Noble Life Sciences - Novotech - PRA Health - Parexel - Pfizer - Protagen - Quintiles - Recipharm - Sanofi - Simbec Research - Sun Pharma - WuXi PharmaTech For more information visit http://www.researchandmarkets.com/research/3x...t_research
LH: 137.39 (-0.44)
Injectable Drug Delivery Market: By Devices, Therapeutics & Formulations 2015 - 2020
M2 - Wed Sep 30, 8:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ltfg29/injectable_drug) has announced the addition of the "Injectable Drug Delivery Market:By Devices, Therapeutics & Formulations (2015 - 2020)" report to their offering. The global injectable drug delivery devices market is expected to increase from around $ 11.6 bn in 2013 to around $ 17.5 bn in 2018. Self-injection devices are expected to grow at the highest growth rate of 16.1% with conventional injection devices growing at only 7.4% during the forecast period 2013 - 2018. The Global Injectable Drug Delivery Devices Market has been analyzed with respect to the demand for devices from different countries across the globe. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2020. The drug injection devices market has been segmented into conventional injectors and self-injection devices broadly. Similarly the drug formulations market has been segmented into the conventional drugs and novel drugs segments. The therapeutic areas are further segmented and analyzed in this report. While conventional devices are growing at a CAGR of 7.37%, self-injection devices are expected to grow at 16.6% during 2013 - 2018. Conventional injection devices hold around 87% market share currently but this is expected to decrease to around 83% by 2018, as the use of self-injection devices increases in the next 5 years. Analyzing the competitive landscape of the global conventional injectable devices market for 2012 the report puts forward the opinion that Becton Dickinson & Co. had the top position with a market share of around 27% followed by Baxter International Inc with a share of 23%. Overall these two companies along with Terumo Corporation and Schott AG together held market share of around 85%. Key Topics Covered: 1. Market Overview 2. Executive Summary 3. Market Landscape 4. Global Injectable Drug Delivery - Market Forces 5. Global Injectable Drug Delivery Market - Strategic Analysis 6. Global Injectable Drug Delivery Market - By Type 7. Global Injectable Drug Delivery Market - By Type of Diseases 8. Global Injectable Drug Delivery Market - Geographic Analysis 9. Market Entropy 10. Company Profiles 11. Appendix Companies Mentioned - Becton Dickinson and Company (BD) - Baxter International Inc. - Consort Medical PLC - Crossject SA - Eli Lilly and Company - Elcam Medical - Novo Nordisk - Owen Mumford Ltd - Sanofi - Schott AG - Terumo Corporation - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/lt...table_drug
BDX: 179.50 (-2.05), NVO: 44.88 (-0.69), BAX: 47.49 (-0.71), LLY: 81.16 (-0.13)
Drug Delivery Market Analysis - Forecast (2015-2020) - Prominent Players are 3M, Abbott Laboratories, Thermo Fischer Scientific, Medtronics, Roche & Baxter
M2 - Wed Jan 20, 5:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/wktqdq/drug_delivery) has announced the addition of the "Drug Delivery Market Analysis - Forecast (2015-2020)." report to their offering. The practice of drug delivery has changed dramatically in the last few decades. With Drug Delivery devices, medication discovered using the most advanced molecular biology strategies and having unacceptable side effects dues to drug interaction with parts of the body that are not target of drugs can be avoided. Drug delivery systems control the rate at which a drug is released and the target in the body where it is released. Side effects limits our ability to treat many diseases like neurodegenerative diseases, cancer, and infectious diseases; it is possible now with drug delivery devices. Administration of drug locally rather than systemically is a way to reduce side effect and drug toxicity and obtain maximum treatment impact. Application of ointment locally and injection of steroid to avoid joint pain are the few older ways to systemic delivery, there can be other ways to deliver drug systemically but some medications can be given only systemically. Here the role of drug delivery device comes into play. In this report different market aspects are explored with particular focus on key market drivers, challenges, constraints and market landscape. The Global market has been thoroughly analyzed and carefully segmented by geographic locations based on major economic and topographical regions. The market is classified into several categories based on technology, applications and end users. Insulin Pen & Pump is the biggest revenue generating segment by type of technology used. Major market players are profiled along with company overview, financial status, business strategies, product portfolio, recent trends and developments. Companies Mentioned: - 3M - Abbott Laboratories - Abbvie - Baxter - B Braun - Consort Medical - Eli-Lilly - Hospira - Hill-Rom - Insulet - Mylan - Medtronic - Omron - Paragard - Roche - Smiths Medical - Thermo Fischer Scientific - Unilife - Zyno medical Key Topics Covered: 1. Market Overview 2. Executive Summary 3. Market Landscape 4. Market Forces 5. Government Regulations 6. Strategic Analysis 7. By Type 8. By Application 9. By End Users 10. Geographic Analysis 11. Market Entropy 12. Company Profiles For more information visit http://www.researchandmarkets.com/research/wk...g_delivery
ABT: 42.19 (-0.03), MDT: 87.71 (-0.11)
Global COPD and Asthma Devices Market Industry Analysis 2015-2019
M2 - Thu Nov 12, 9:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/vb94x6/global_copd_and) has announced the addition of the "Global COPD and Asthma Devices Market - Industry Analysis 2015-2019" report to their offering. The global COPD and asthma devices market to grow at a CAGR of 3.76% over the period 2014-2019. The report, Global COPD and Asthma Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends. Vendors are expanding online marketing and promotional activities to provide better accessibility of their products to customers and increase product sales. This strategy also allows vendors to minimize sales mediators, distribution, and reduce operational costs. Many small, medium, and large vendors sell inhalers and nebulizers and their accessories online, proving to be a convenience for consumers. Some of the vendors also provide discounts and promotional offers online, which has increased the overall online purchase. The products offered online also come with a warranty or guarantee from the manufacturer. According to the report, the rising incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis increases the demand for aerosol drug delivery devices. Exposure to allergens, smoking, and infections in the respiratory tract could cause the lungs to fill with mucus, leading to breathing difficulties. Using aerosol-based mechanism allows the drugs to reach the lungs immediately, helping the person breathe. We also expect the growing use of home medical devices to propel market growth. Home healthcare devices are reliable, comfortable, and easy to use. Further, the report states that stringent government regulations regarding the safety, quality, and efficacy of COPD and asthma devices hinder market growth. The devices have to comply with numerous standards to enter the market. Obtaining approval is both a lengthy and costly process. To calculate the market size, the report considers revenue generated from the sales of following COPD and asthma devices: - Inhalers - Nebulizers Key vendors - Consort Medical - Gerresheimer - Nypro - Philips Healthcare - RPC Bramlage Other prominent vendors - Aerogen - Airon - Allied Healthcare - AstraZeneca - Boehringer Ingelheim - Briggs Healthcare - Cardinal Health - Clement Clarke International - DeVilbiss Healthcare - Drive Medical - GlaxoSmithKline - Heyer Medical - Invacare - Omron Healthcare - PARI Medical - Salter Labs - Smart Inhaler - Sunovion Pharmaceuticals - Teleflex - Vortran Medical For more information visit http://www.researchandmarkets.com/research/vb...l_copd_and
IVC: 10.99 (-0.07), GSK: 43.42 (-0.16)
Leading 200 Global Multinational Medical Devices/Technology/Supplies Companies with Major Manufacturing and R&D
M2 - Thu Oct 22, 2:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nngj7n/_global) has announced the addition of the " Global Geographic Frontiers Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 global multinational medical devices/technology/supplies companies with manufacturing and research, and covers various analyses to identify countries that should be considered by such companies for new medical devices manufacturing and research. When it comes to medical device product development, the fragmentation of the industry can be challenging. Medical device development and manufacturing have seen many changes in the last decade. Not too long ago, manufacturing anything in a different country was risky and time intensive but now new communication technologies have allowed for the rapid development and manufacturing of medical devices overseas which has reduced costs and time to market. Developed and developing countries are investing in high quality medical device manufacturing facilities that allow sourcing of design and manufacturing throughout the world. However, recently, the medical device manufacturers have also been looking beyond their traditional markets in the United States and EU, focusing instead on emerging economies such as Brazil, Russia, India, and Chinacollectively known as the BRIC nations for growth. But as companies flock to the BRICs and the medtech markets in these countries mature, forward-thinking device makers are searching for the next group of emerging medtech markets. Among those that show promise are the 10 countries that comprise the Association of Southeast Asian Nations (ASEAN)Indonesia, Malaysia, the Philippines, Singapore, Thailand, Brunei, Myanmar, Cambodia, Laos, and Vietnam. Highlights - Identifies leading global multinational medical devices/technology/supplies companies with major manufacturing and R&D - Identifies top 200 among such companies based on total sales, net income, total assets, and total equity - Identifies home and foreign countries for manufacturing and research facilities of leading global geographic frontiers medical devices/technology/supplies companies - Summary of company news for expansion into new countries for leading global medical devices/ technology/supplies companies - Summary of initiatives taken up by government countries to support setting up of manufacturing facilities - Comprehensive listing of leading global geographic frontiers medical devices/technology/supplies companies covered in the study Key Topics Covered: 1: GMD Sales, R&D Expenses, and Foreign Sales for Top 25 Countries by Population 2: Leading 200 Global Multinational Medical Devices/Technology/Supplies Companies with Major Manufacturing and R&D (based on total sales, net income, total assets, total equity) 3: Home Countries having Manufacturing Units in Foreign Countries 4: Home Countries having Research & Development Units in Foreign Countries 5: Popular Foreign Countries for Manufacturing Units 6: Popular Foreign Countries for Research & Development Units 7: Comparison of Manufacturing and Research & Development Units of Home and Foreign Companies in Home Countries 8: Global Medical Devices/Technology/Supplies Companies which Expanded into New Countries in Last 2 Years 9: Government Initiatives to Support Setting Up of Manufacturing Facilities for Medical Devices/Technology/Supplies Companies Mentioned - Partial List - Biotage AB - Boston Scientific Corporation - Boule Diagnostics AB - Bruker Corporation - CRH Medical Corp. - Cambridge Cognition Holdings Plc - Cardica, Inc. - Carl Zeiss Meditec AG - Cellavision AB - Coloplast AS - Coltene Holding AG - Comet Holding AG - Conmed Corporation - Consort Medical Plc - ContextVision - Cooper Companies, Inc. - Cormedix - Covidien Plc - Cutera, Inc. - Cyberoptics Corporation - Cyclopharm Limited - Cynosure Inc - Danaher Corp. - Dentsply International Incorporated - DiaSorin Inc. - Dipped Products Plc - Draegerwerk AG & Co KGaA - EKF Diagnostics Holdings PLC For more information visit http://www.researchandmarkets.com/research/nngj7n/_global
CYNO: 52.93 (-1.24), CRHM: 3.95 (-0.11), DHR: 77.59 (-0.08), COO: 180.97 (-3.53), BSX: 23.71 (-0.02), CRDC: 2.35 (-0.15)
Contract Research Organization Market - Global Deals and Operational Strategies
M2 - Thu Oct 08, 3:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3xpsnr/contract_research) has announced the addition of the "Contract Research Organization Market - Global Deals and Operational Strategies" report to their offering. This report discusses the deals that took place in the CRO space between 2010 and April 2015, giving a thorough analysis of the major deals, operational and service strategies, and financials of key players. This report discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs. The operational strategies adopted by key players in the recent years have been listed. A heatmap analysis of the key companies was done based on their firm utilization and capital management. SWOT analysis and profiles are given for the key companies in the market. Recent years have seen pharmaceutical companies struggling to balance R&D expenditure and profitability due to the rising costs of drug development and clinical trials, along with rigorous regulatory and quality assurance requirements. In a bid to boost profit margins, companies are outsourcing R&D and clinical trial activities to Contract Research Organizations (CRO) to achieve far more at a far lower cost. Scope - Overview of key reasons behind outsourcing, outsourcing service models - Examples of operational strategies - Global deals analysis by type and value - Major acquisitions and partnerships - Regional analysis of North America, Europe, Asia-Pacific and Emerging markets - Company benchmarking based on heatmap analysis - Vendor positioning - SWOT analysis and profiles of key players Key Reasons to Purchase - Identify the top players in the CRO market, financial revenues and key services offered - Analyze the key geographies that are lucrative markets for deal making, market-entry and market expansion strategies - Analyze the trends in acquisitions, licensing and other type of deals and explore potential investment opportunities - Understand the operational strategies of key players Key Topics Covered: 1. Executive Summary 2. Introduction 2.1 Market Dynamics 2.2 Operating Models 2.3 Examples of Operational Strategies 3. Global Deal Analysis 3.1 Collaborations and Acquisitions 3.2 Major Acquisitions 3.3 Major Partnerships 4. Regional Analysis 4.1 North America 4.2 Europe 4.3 Asia-Pacific 5. Emerging Markets 5.1 Market Assessment 5.2 Acquisitions 5.3 Firm Utilization 5.4 Firm Utilization and Capital Management 5.5 Company Benchmarking 5.6 Vendor Positioning 6. Profiles and SWOT Analysis 7. Appendix Companies Mentioned - Almac Group - Assign - Aurigon - Avillion - BioPharma - CMIC Holdings - Carlina - Catalent - Celonic and PharmaLex - Charles River - Chiltern International - Consort Medical - Covance - Cromos Pharma - EPS Corporation - Euprotech - Eurofins Scientific - Hangzhou Tigermed - Harlan Labs - ICON - Laboratory Corporation of America Holdings - MPI Research - Meiji Seika - Noble Life Sciences - Novotech - PRA Health - Parexel - Pfizer - Protagen - Quintiles - Recipharm - Sanofi - Simbec Research - Sun Pharma - WuXi PharmaTech For more information visit http://www.researchandmarkets.com/research/3x...t_research
LH: 137.39 (-0.44)
Injectable Drug Delivery Market: By Devices, Therapeutics & Formulations 2015 - 2020
M2 - Wed Sep 30, 8:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ltfg29/injectable_drug) has announced the addition of the "Injectable Drug Delivery Market:By Devices, Therapeutics & Formulations (2015 - 2020)" report to their offering. The global injectable drug delivery devices market is expected to increase from around $ 11.6 bn in 2013 to around $ 17.5 bn in 2018. Self-injection devices are expected to grow at the highest growth rate of 16.1% with conventional injection devices growing at only 7.4% during the forecast period 2013 - 2018. The Global Injectable Drug Delivery Devices Market has been analyzed with respect to the demand for devices from different countries across the globe. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2020. The drug injection devices market has been segmented into conventional injectors and self-injection devices broadly. Similarly the drug formulations market has been segmented into the conventional drugs and novel drugs segments. The therapeutic areas are further segmented and analyzed in this report. While conventional devices are growing at a CAGR of 7.37%, self-injection devices are expected to grow at 16.6% during 2013 - 2018. Conventional injection devices hold around 87% market share currently but this is expected to decrease to around 83% by 2018, as the use of self-injection devices increases in the next 5 years. Analyzing the competitive landscape of the global conventional injectable devices market for 2012 the report puts forward the opinion that Becton Dickinson & Co. had the top position with a market share of around 27% followed by Baxter International Inc with a share of 23%. Overall these two companies along with Terumo Corporation and Schott AG together held market share of around 85%. Key Topics Covered: 1. Market Overview 2. Executive Summary 3. Market Landscape 4. Global Injectable Drug Delivery - Market Forces 5. Global Injectable Drug Delivery Market - Strategic Analysis 6. Global Injectable Drug Delivery Market - By Type 7. Global Injectable Drug Delivery Market - By Type of Diseases 8. Global Injectable Drug Delivery Market - Geographic Analysis 9. Market Entropy 10. Company Profiles 11. Appendix Companies Mentioned - Becton Dickinson and Company (BD) - Baxter International Inc. - Consort Medical PLC - Crossject SA - Eli Lilly and Company - Elcam Medical - Novo Nordisk - Owen Mumford Ltd - Sanofi - Schott AG - Terumo Corporation - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/lt...table_drug
BDX: 179.50 (-2.05), NVO: 44.88 (-0.69), BAX: 47.49 (-0.71), LLY: 81.16 (-0.13)
(0)
(0)Scroll down for more posts ▼